1.Revision of the Chinese Version of the FACT-B for Patients with Breast Cancer
Chonghua WAN ; Dongmei ZHANG ; Xuelian TANG
Chinese Mental Health Journal 1991;0(05):-
Objective: To revise and evaluate the Chinese version of the FACT-B. Method: The Chinese version of the FACT-B was translated from the original one, after back-translated and culture adaptation, it was applied to 165 patients with breast cancer. Result: The test-retest reliability of five domains, such as physical well-being, social/family well-being, emotional well-being, functional well-being, additional concerns and the overall scale were 0.82~0.89. The internal consistency alpha for the five domains were 0.61~0.84. After admission to hospital 2-4 weeks, the quality of life of patients showed some change in this scale. Conclusion: The Chinese version of the FACT-B has good psychometric quality and can be used to assess the quality of life of Chinese patients with breast cancer.
2.Fuzhengzhiqiu Granules' effect on ICAM-1 and VCAM-1 expression in nasal mucosa of experimental allergic rhinitis
Chaoping ZANG ; Hongmeng YU ; Yurong GU ; Chunquan ZHENG ; Chonghua ZHANG
Chinese Traditional Patent Medicine 1992;0(05):-
Objective: To investigate Fuzhengzhiqiu Granules' effect on ICAM-1(Intercellular adhesion molecule-1) and VCAM-1(Vascular cell adhesion molecule-1) expression in nasal mucosa of experimental allergic rhinitis. Methods: SD rats (n=64) were immunized by intraperitoneal injection of 200?g Ovalbumin (OVA) (1ml OVA-Al[OH] 3-saline suspension) on 1st, 2ed and eleven day. Normal control group rats A (n=16) were treated with the same methods except injecting OVA. 19th day, 0.1 ml of saline containing 10 mg of OVA was instilled into nasal cavity for 7 consecutive days. Normal control group followed by intranasal administration only with saline. The rats challenged into allergic rhinitis (n=64) were randomly divided into four groups: allergic rhinitis model group B (n=16); Fu zhengzhiqiu Granules treated group C (n=16); Fu zhengzhiqiu Granules treated group D (n=16, three times dosage used in group C); Xinqin Granules treated group E (n=16). All animals were treated for 15 days. The nasal mucosa of them were studied by immunohistochemical staining to observe the ICAM-1 and VCAM-1 expression. Results: Animal model of allergic rhinitis was established by using ovalbumin intraperitoneal immunization and nasal challenge. The number of positive immunoreactive cells (ICAM-1 and VCAM-1) was increased significantly in all the groups compared with normal controls. VCAM-1 expression was inhibited by giving with Fuzhengzhiqiu Granules (especially in group D) and Xinqin Granules (P0.05). Conclusion: Fuzhengzhiqiu Granules can decrease the expression of VCAM-1 in nasal mucosa of experimental allergic rhinitis, but no effect on ICAM-1.
3.Development and Preliminary Evaluation of Quality of Life Instruments for Chronic Diseases-Osteoarthritis (QLICD-OA)
Xiaoqing ZHANG ; Fenglan ZHANG ; Chonghua WAN ; Xiaomei LI ; Zhaoping LV ; Haiyan PAN
Journal of Kunming Medical University 2013;(8):23-27
Objective To develop and evaluate the Quality of Life Instruments for Chronic Diseases -Osteoarthritis ( QLICD-OA). Methods The QLICD-OA was evaluated by testing 140 in-patients with Osteoarthritis. The statistical methods used included correlation analysis, factor analysis, paired t test and Generalizability coefficient. Results The rest-retest reliability γ of QLICD-OA was 0.91, Cronbach’s α for overall scale was 0.98 and Generalizability coefficient was 0.94. Correlation and factor analysis demonstrated good construct validity. After treatment, statistically significant scores were found in the tested group for Specific module and total instrument. Conclusions The QLICD-OA has good validity, reliability and responsiveness. The QLICD-OA may serve as the QOL measurement scale for patients with Osteoarthritis in China.
4.Metric evaluation of quality of life instruments for cancer patients-brain neoplasm (QLICP-BN)
Xiaoyu HAN ; Jun HE ; Chonghua WAN ; Jiahong LUO ; Gang BAI ; Jianghui ZHANG ; Qiong MENG
Journal of International Oncology 2021;48(3):143-149
Objective:To understand the reliability and validity of quality of life instruments for cancer patients-brain neoplasm [QLICP-BN (V1.0)], a self-developed quality of life scale for cancer patients.Methods:The quality of life of 112 patients with brain neoplasms in Yunnan Cancer Hospital from March 2012 to November 2013 was measured. The general data questionnaire and QLICP-BN (V1.0) were used for data collection. The reliability, validity and responsiveness of the scale were tested, and then the metric characteristics of the scale were evaluated.Results:The split-half reliability of the total score of the scale was 0.95, the Cronbach αcoefficient was 0.92, and the test-retest correlation coefficient rwas 0.78. After extracting common factors by the principal component method and rotating with the maximum variance, the specific module obtained three principal components, and the cumulative variance contribution rate was 64.18%. The score of specific module was 75.30±17.44 before treatment and 78.91±12.20 after treatment ( t=-2.481, P=0.015). The total score of scale before treatment was 65.26±12.29, and that after treatment was 69.62±10.41, with a statistically significant difference ( t=-4.492, P<0.001). The total responsiveness of the scale was 0.456, showing moderate responsiveness. Conclusion:QLICP-BN (V1.0) has good reliability, validity and a certain degree of responsiveness. It can be used as a measurement tool for the quality of life of patients with brain neoplasms in China.
5.Evaluation of quality of life instrument for nephrotic syndrome based on generalization theory and item response theory
Yue LIN ; Xingshan ZHANG ; Junhao GUO ; Wendan CHEN ; Chonghua WAN ; Haiyan PAN
Chongqing Medicine 2024;53(9):1295-1300
Objective To evaluate the performance of the Quality of Life Instrument for Chronic Dis-ease Nephrotic Syndrome [QLICD-NS(V2.0)] in patients with nephrotic syndrome.Methods A total of 203 patients with nephrotic syndrome (NS) diagnosed in the Department of Nephrology,Affiliated Hospital of Guangdong Medical University from March 2021 to November 2021 were selected for QLICD-NS(V2.0) eval-uation,and the evaluation methods were generalization theory (GT) and item response theory (IRT).The dif-ficulty,discrimination coefficient and information amount of each item were obtained by using Multilog 7.0 software to analyze the grade response model (GRM) of IRT.Results The results of GT showed that the contribution ratio of the global total score in the four domains of QLICD-NS(V2.0) scale was evenly distribu-ted,and the generalization coefficient of the four domains was greater than 0.50.Except for social function,the variance component of the participants in the other three domains were greater than the item variance compo-nent,and the reliability index of each domain was greater than 0.50.The results of IRT showed that the dis-crimination degree of QLICD-NS(V2.0) scale was 0.82.Except for items TNS7 and TNS8,the difficulty coef-ficients of the other items ranged from -3 to 3 and increase monotonically.Conclusion The QLICD-NS (V2.0) scale has good reliability in physiological function and psychological function,and is acceptable in so-cial field and special function.The QLICD-NS(V2.0) scale developed in this study has good performance.
6.The application value of urine γ-synuclein in the diagnosis of bladder cancer
Yabin HOU ; Yuqin DOU ; Hairu WANG ; Jie REN ; Yu ZHANG ; Chonghua HAO
Cancer Research and Clinic 2021;33(9):673-676
Objective:To explore the application value of urine γ-synuclein (SNCG) in the diagnosis of bladder cancer.Methods:A total of urine samples from 129 patients with bladder cancer (malignant lesion group), 157 patients with urinary system benign lesions (benign lesion group), and 177 healthy people (the healthy control group) from January 2017 to April 2020 in the Fifth Clinical Medical College of Shanxi Medical University and Shanxi Provincial Cancer Hospital were collected. The concentration of SNCG in the collected urine was detected by using enzyme-linked immunosorbent assay. The receiver operating characteristic (ROC) curve was drawn to determine its sensitivity, specificity and accuracy for the diagnosis of bladder cancer.Results:The urine SNCG concentration in malignant lesion group [4.28 ng/ml (0.53-8.79 ng/ml)] was higher than that in healthy controls [1.44 ng/ml (0.56-3.51) ng/ml, H = 122.9, P < 0.01] and benign lesion group [1.97 ng/ml (0.51-5.87) ng/ml, H = 88.2, P < 0.01], and the concentration of urine SNCG in benign lesion group was higher than that in healthy controls ( H = 17.1, P < 0.01). ROC area under the curve (AUC) of urine SNCG in differentiating benign lesion group from healthy controls was 0.871(95% CI 0.819-0.923, P < 0.01), the best cut-off value was 2.79 ng/ml, the diagnostic sensitivity and specificity was 0.798 and 0. 977, respectively. AUC of urine SNCG in differentiating malignant lesion group from benign lesion group was 0.823(95% CI 0.769-0.877, P < 0.01), the best cut-off value was 3.54 ng/ml, the diagnostic sensitivity and specificity was 0.713 and 0.917, respectively. AUC of urine SNCG in differentiating malignant lesion group from healthy controls plus benign lesion group was 0.848 (95% CI 0.797-0.899, P < 0.01), the best cut-off value was 2.87 ng/ml, the diagnostic sensitivity and specificity was 0.791 and 0.901, respectively. Conclusions:The concentration of SNCG in urine of patients with bladder cancer is higher than that of patients with benign urinary lesions and healthy people. Urine SNCG has a good application value in the diagnosis of bladder cancer.
7.Development and responsiveness of the coronary heart disease scale in the patient reported outcomes instruments system for chronic diseases
Chuanmeng ZHANG ; Zhiwen HUANG ; Chonghua WAN ; Zheng YANG ; Chuanzhi XU
Chinese Journal of Modern Nursing 2018;24(17):1991-1995
Objective To develop the coronary heart disease (CHD) scale in the patient reported outcomes instruments system for chronic diseases (PROISCD-CHD), to assess its responsiveness and to offer a basis for clinical application.Methods The scale was developed by combining general and specific modules in accordance with the process by China Food and Drug Administration (CFDA). PROISCD-CHD was used to score the patient reported outcomes in 157 CHD patients before and after treatment in order to assess its responsiveness. The pairedt test and the responsiveness indicator before and after adopting the scale for treatment were used to analyze the data.Results The developed PROISCD-CHD included 30 items in the general module and 15 items in the specific module. According to the pairedt test, there was statistically significant difference in all aspects/dimensions other than ability and activity limited, positive emotions (P<0.05). In terms of the responsiveness indicator, the value range forSRM/ES andCR was 0.20-0.50 and 5.00%-15.00%, respectively, indicating the responsiveness was medium, except for some aspects/dimensions. Conclusions The general and specific modules in PROISCD-CHD includes the full content of CHD. Meanwhile, it has a certain responsiveness, and can be an assessment tool for China's patient reported outcomes for CHD.
8.Insecticide resistance tendency and prevention strategies of Aedes albopictus in Yangpu District, Shanghai, China
Jie ZHANG ; Chonghua LU ; Lili ZONG ; Xiaoyan LU ; Hongxia LIU
Shanghai Journal of Preventive Medicine 2022;34(2):109-112
Objective To investigate the resistance development of
9.The resistance dynamics of Blattella germanica in Yangpu District of Shanghai from 2014 to 2020
Chonghua LU ; Jie ZHANG ; Jie ZHAO ; Jiwei WANG ; Fei WANG ; Xiaoyan LU
Shanghai Journal of Preventive Medicine 2022;34(2):123-125
Objective To investigate the resistance dynamics of
10.Patient delay and influencing factors of the elderly patients with pulmonary tuberculosis in Huai'an
Dizhong FENG ; Fuhua HE ; Chonghua ZHANG ; Qingling WAN ; Dengjun WU
Journal of Public Health and Preventive Medicine 2021;32(6):111-114
Objective To study patient delay and the influencing factors of the elderly patients with pulmonary tuberculosis(PTB),so as to provide evidence for developing effective prevention and control strategies. Methods Derived the information from PTB management information system in 2010-2019 of the tuberculosis patients who were aged 60 years or older in Huai'an City, described and analyzed the influencing factors of patient delay. Results The median time of PTB patients delay in Huaian was 21 day, while the rate was 65.91%. Multivariate logistic regression analysis results showed that compared with permanent residents, city dwellers, the first diagnosis unit specialized hospital, and the patient source referral, the patient delay risks of the floating residents(OR = 2.942 , 95% CI: 2.461-3.518), the country dwellers(OR = 1.528,95% CI :1.377-1.697), the first diagnosis unit general hospital(OR = 1.203,95% CI: 1.087-1.333), and the patient source recommendation (OR = 2.395,95% CI: 1.960-2.928)were higher, Compared with the peasants(OR = 0.315 , 95% CI : 0.213-0.512), new patients(OR = 0.812 , 95% CI : 0.689-0.974) and sputum smear positive patients(OR = 0.866 , 95% CI : 0.780-0.962), the patient delay risks of the non-peasants, recurrent patients, and sputum negative patients were lower. Conclusion The patient delay of the elderly patients with pulmonary tuberculosis(PTB)in Huaian was serious, the influencing factors of patient delay were type of household registration, current residence, occupation, type of first-time unit, source of patient , classification of treatment, and the sputum test results.